Herceptin (trastuzumab)

trastuzumab · Genentech

Drug timelines are a Plus or Pro feature.

5 regulatory and trial events tracked for Herceptin (trastuzumab), covering 2015-12-28 to 2026-04-07. Get the full timeline:

Most recent: Clinical Trial Update: ShortStop-HER2: 12 Months vs. 6 Months of HER2-targeted Medications for People With HER2+ Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Trastuzumab [Phase 3]

See pricing